The Respert 24: Twenty Four Points to Guide Your CYDY

New Post Public Reply Private Reply Replies (2) Message Board
Respert24
1,050
The Respert 24: Twenty Four Points to Guide Your CYDY Investment

1) I'm on the first point and already mad at myself for promising 24 of these. But first and foremost make sure you're OK adjusting expectations on the fly because it is near impossible to nail down a true timeline.

2) There are only a small handful of posters here that you should follow and believe. They've been in it a long time and have a tremendous grasp of reality and science. I'd name them all but after taking a quick glance at my dwindling wine supply I'm worried I'd throw a LeaveYourMomsBasementAndEatLotsOfCannolis in the mix by accident. And let me make that a double shoutout because I've never seen anyone more dedicated to following a board just to relentlessly dislike posts. Cycl2r is a close second. I probably butchered the spelling of each of their screen names but that's fitting. And like I said before...wine...

3) LISTEN TO OHM20. I enjoy the hell out of Ohm20's science-based-mic-drop posts but I'm beginning to like his annoyed-with-trolls posts even more.

4) The company has to keep some things secret. Get used to it. They can't tell us every friggin thing they're thinking or planning and give the competition their secrets, ya turds. When investors beat down NP with enough questions and he eventually gives out a little extra color around a subject everyone loses their shit. It's ridiculous because if there ever was a company (at least up until the last month) that was eager to tell you as much as possible it was NP and Cytodyn. The fact that they aren't telling us everything is because it isn't helping so relax. #yaturds

5) Optimal blackjack strategy is based on odds. If you have a 15 or 16 against a dealer 10 you need to hit. It doesn't matter if the players before you all hit small cards. You still need to hit. I could easily relate this to Cytodyn investing but I think I'm just going to let this stand because I'm guessing at least a few of you need to see this message without any distractions. Stop undermining your investment because of a third party making poor decisions. Shit, I kinda just related it back to Cytodyn by accident.

6) We don't get the kind of media exposure we'd like but I'd like to counter that we've actually gotten quite a bit for a tiny company that would literally be at or near the bottom of any list of companies comparing their junk size. The popular girls are all giggling over the big pharma boys and Cytodyn is George Costanza getting noticed at the wrong time, desperately yelling "IT WAS COLD! THERE WAS SHRINKAGE!!!" To continue the Seinfeld connection there will come a point where NP pulls the soup nazi's recipes (CD12 Results) out of the credenza (maze of FDA-required trials and tribulations) and slaps it around in his (The world's) face. That last bit may have been a stretch but wine.

7) Scott Kelly reminds me of the actor Marc Evan Jackson (from Brooklyn 99). This shouldn't impact your investment at all but I said I'd do 24. This is your fault, not mine. I have a reputation to uphold.

8) Screw that reputation I can't do 24. I'm gonna finish this Bogle Phantom and judge you all by whether or not you like my posts. Good luck to all of us. Hopefully we see what we've all been waiting for this week. The results, if positive, will change many lives in many ways. Keep it crispy.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boots Group Wraps Up Consent Solicitation for Notes

Updated Category News Views 3

Consent Solicitation's Critical Role in Acquisition No time for dawdling—Boots Group's gathered up their consent cards for hefty senior secured notes, and we're talking close to a billion smackers here. It's a bold move to grease the wheels on looming acquisition maneuvers. We're looking at a €650 million and a £375 million stack of senior secured notes patiently...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
Gildan Activewear Faces 18.8% Hit Amid Securities Suit

Updated Category News Views 3

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 34

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Callender Bowlin's Legal Eagles Soar in Texas 2026

Updated Category News Views 38

The Spotlight on CB Trial's Legal Titans Roll the dice, folks—who stands up in Texas’ legal playground? It's Callender Bowlin, PLLC's hotshots again securing their hallmark in the 2026 Texas Super Lawyers gauntlet. This ain’t their first rodeo, either. Founding partners Mark Callender and Josh Bowlin—names synonymous with high-stakes litigation—continue to bask...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 135

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 21

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 24

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading

Top 5 Most Recently Viewed Articles

Lamar Advertising to Engage at Major CEO Conference in 2025

Updated Category News Views 226

Exciting Participation at the Citi 2025 Global Property CEO Conference Lamar Advertising Company (Nasdaq: LAMR), a leading name in outdoor advertising, is gearing up for a significant appearance at the upcoming Citi 2025 Global Property CEO Conference. Scheduled for March 3, 2025, Sean Reilly, the company's CEO, will take center stage to engage in a lively...

Continue Reading
Venu Holding Corporation Explores Partnership with Troy Aikman

Updated Category News Views 214

Venu Holding Corporation Explores Partnership with Troy Aikman Venu Holding Corporation (“VENU”) (NYSE American: VENU) has exciting news to share! Recently, an exclusive interview was presented on TMZ Sports featuring NFL Hall of Famer Troy Aikman, who is also the owner of EIGHT Elite Light Lager, alongside J.W. Roth, the talented Founder, Chairman, and CEO of VENU....

Continue Reading
Third Century Bancorp's Commitment to Shareholder Dividends

Updated Category News Views 43

Third Century Bancorp Declares Dividend Third Century Bancorp (OTCPINK: TDCB), the parent company of Mutual Savings Bank, has made a noteworthy announcement about its dedication to enhancing shareholder value. The company has declared a dividend of $0.05 per share, reflecting its solid financial health. Shareholders should note that this dividend is applicable to those...

Continue Reading
Discover Modern Meadow's Exciting Innovations at Lineapelle 2025

Updated Category News Views 353

Modern Meadow Showcases Innovations at Lineapelle 2025 Modern Meadow, a pioneer in sustainable materials, is set to make waves at the upcoming Lineapelle 2025 exhibition. This prestigious event, dedicated to the world of leather and related products, offers an excellent platform for showcasing their advanced, renewable biomaterials. Visitors can find Modern Meadow in Hall...

Continue Reading
C3 AI Plans Financial Results Announcement for Q3 FY2025

Updated Category News Views 285

C3 AI Plans Financial Results Announcement for Q3 FY2025 C3 AI (NYSE: AI), the leader in enterprise AI application software, is set to share its financial performance for the third quarter of the fiscal year 2025. This significant event is scheduled to happen after the close of the U.S. markets, marking an important moment for the company and its stakeholders....

Continue Reading